Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.
Yang CW, Lee YZ, Hsu HY, Jan JT, Lin YL, Chang SY, Peng TT, Yang RB, Liang JJ, Liao CC, Chao TL, Pang YH, Kao HC, Huang WZ, Lin JH, Chang CP, Niu GH, Wu SH, Sytwu HK, Chen CT, Lee SJ.
Yang CW, et al. Among authors: chao tl.
Front Pharmacol. 2020 Dec 14;11:606097. doi: 10.3389/fphar.2020.606097. eCollection 2020.
Front Pharmacol. 2020.
PMID: 33519469
Free PMC article.